COVID-19 & CancerFreeGuest Editorial With the COVID-19 pandemic, the cancer clinical trials—they are a-changing May 08, 2020Vol.46 No.19By Gregory Masters, Nicholas J. Petrelli and Kandie Dempsey
COVID-19 & CancerFreeGuest Editorial Embracing the increasing value of eHealth in patient-centered cancer care during the COVID-19 pandemic and beyond May 08, 2020Vol.46 No.19By Frank J. Penedo and Joshua Kronenfeld
FreeObituary Paul A. Marks, architect of modern academic oncology who led MSK for two decades, dies at 93 May 08, 2020Vol.46 No.19By Larry Norton
COVID-19 & CancerFree Fox Chase will not be sold to Jefferson after allDeal becomes a “casualty of COVID-19” May 08, 2020Vol.46 No.19By Paul Goldberg
COVID-19 & CancerFreeGuest Editorial COVID-19 and community cancer careA Panorama of a Catastrophe May 08, 2020Vol.46 No.19By Debra Patt and Michael Kolodziej
Clinical RoundupFree Phase III trial evaluating Libtayo in NSCLC halted because of significant OS improvement May 01, 2020Vol.46 No.18
Clinical RoundupFree Lynparza demonstrates OS benefit in phase III prostate cancer trial May 01, 2020Vol.46 No.18
Clinical RoundupFree GARNET study demonstrates potential of dostarlimab to treat recurrent or advanced endometrial cancer May 01, 2020Vol.46 No.18
Clinical RoundupFree MD Anderson, Ipsen advance therapy with potential benefit for patients with lung, ovarian cancer May 01, 2020Vol.46 No.18
